Scribe Therapeutics (NASDAQ:SCTX) Major Shareholder Bio Fund Ii L.P. Ah Purchases 333,333 Shares of Stock

Scribe Therapeutics Inc. (NASDAQ:SCTX) major shareholder Bio Fund Ii L.P. Ah acquired 333,333 shares of the stock in a transaction on Monday, July 27th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $4,999,995.00. Following the completion of the transaction, the insider owned 2,385,075 shares in the company, valued at approximately $35,776,125. This represents a 16.25% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Scribe Therapeutics Price Performance

NASDAQ:SCTX traded up $0.30 during trading hours on Wednesday, hitting $18.36. 325,049 shares of the stock traded hands, compared to its average volume of 390,915. Scribe Therapeutics Inc. has a fifty-two week low of $17.31 and a fifty-two week high of $25.49.